Table 2.
INITIAL DOSE OF REGORAFENIB, MG/DAY | n (%) |
---|---|
160 | 10 (34) |
120 | 17 (59) |
80 | 2 (7) |
Dose modifications, n (%) | 15 (51) |
Dose reductions, n (%) | 9 (31) |
Median duration of treatment, months (range) | 2.5 (0,13–11,4) |
Reasons for stop, n (%) | |
Progression | 23 (79) |
Toxicity | 6 (21) |
Best response n* (%) | |
Stable disease | 7 (24) |
Progression disease | 20 (69) |
Note:
Missing data.